59.65
price up icon0.25%   0.15
after-market Dopo l'orario di chiusura: 59.65
loading
Precedente Chiudi:
$59.50
Aprire:
$59.58
Volume 24 ore:
437.99K
Relative Volume:
0.28
Capitalizzazione di mercato:
$2.33B
Reddito:
-
Utile/perdita netta:
$-54.42M
Rapporto P/E:
-23.38
EPS:
-2.5513
Flusso di cassa netto:
$-50.87M
1 W Prestazione:
+0.13%
1M Prestazione:
+64.69%
6M Prestazione:
+179.06%
1 anno Prestazione:
+980.62%
Intervallo 1D:
Value
$59.40
$59.69
Intervallo di 1 settimana:
Value
$58.82
$59.95
Portata 52W:
Value
$3.60
$59.95

Longboard Pharmaceuticals Inc Stock (LBPH) Company Profile

Name
Nome
Longboard Pharmaceuticals Inc
Name
Telefono
619-592-9775
Name
Indirizzo
4275 EXECUTIVE SQUARE, LA JOLLA
Name
Dipendente
33
Name
Cinguettio
Name
Prossima data di guadagno
2024-10-31
Name
Ultimi documenti SEC
Name
LBPH's Discussions on Twitter

Longboard Pharmaceuticals Inc Stock (LBPH) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-10-24 Ripresa Cantor Fitzgerald Overweight
2023-04-27 Iniziato B. Riley Securities Buy
2021-04-07 Iniziato Evercore ISI Outperform
2021-04-06 Iniziato Cantor Fitzgerald Overweight
2021-04-06 Iniziato Citigroup Buy
2021-04-06 Iniziato Guggenheim Buy
Mostra tutto

Longboard Pharmaceuticals Inc Borsa (LBPH) Ultime notizie

pulisher
03:17 AM

Vanguard Group Inc's Strategic Acquisition in Longboard Pharmace - GuruFocus.com

03:17 AM
pulisher
Nov 03, 2024

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Position Increased by Emerald Advisers LLC - MarketBeat

Nov 03, 2024
pulisher
Nov 03, 2024

Longboard Pharmaceuticals (NASDAQ:LBPH) Hits New 1-Year High – Here’s What Happened - Defense World

Nov 03, 2024
pulisher
Nov 01, 2024

Longboard Pharmaceuticals (NASDAQ:LBPH) Reaches New 52-Week HighShould You Buy? - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Longboard Pharmaceuticals stock soars to all-time high of $59.95 - Investing.com

Nov 01, 2024
pulisher
Nov 01, 2024

Longboard Pharmaceuticals stock soars to all-time high of $59.95 By Investing.com - Investing.com Australia

Nov 01, 2024
pulisher
Oct 31, 2024

Longboard Pharmaceuticals Inc options imply 0.8% move in share price post-earnings - TipRanks

Oct 31, 2024
pulisher
Oct 31, 2024

LONGBOARD PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Longboard Pharmaceuticals, Inc.LBPH - Business Wire

Oct 31, 2024
pulisher
Oct 28, 2024

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Given Consensus Rating of "Hold" by Analysts - MarketBeat

Oct 28, 2024
pulisher
Oct 28, 2024

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Given Consensus Rating of “Hold” by Analysts - Defense World

Oct 28, 2024
pulisher
Oct 27, 2024

Lundbeck to Buy Longboard Pharma in $2.6 Billion Deal - MSN

Oct 27, 2024
pulisher
Oct 26, 2024

(LBPH) Trading Signals - Stock Traders Daily

Oct 26, 2024
pulisher
Oct 23, 2024

Longboard Pharmaceuticals stock soars to all-time high of $59.48 By Investing.com - Investing.com Australia

Oct 23, 2024
pulisher
Oct 23, 2024

Longboard Pharmaceuticals (NASDAQ:LBPH) Hits New 1-Year HighStill a Buy? - MarketBeat

Oct 23, 2024
pulisher
Oct 23, 2024

Longboard Pharmaceuticals stock soars to all-time high of $59.48 - Investing.com India

Oct 23, 2024
pulisher
Oct 22, 2024

$DRUG 5,900% Weekly Surge Turns Attention. Cybin ($CYBN) Rallying 23% This Week In Anticipation For Major Milestones - FinanceFeeds

Oct 22, 2024
pulisher
Oct 21, 2024

Longboard Pharmaceuticals (NASDAQ:LBPH) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat

Oct 21, 2024
pulisher
Oct 20, 2024

Oklo, CleanSpark And Wolfspeed Are Among Top 7 Mid Cap Gainers Last Week (Oct 14-18): Are The Others In Your Portfolio? - Benzinga

Oct 20, 2024
pulisher
Oct 20, 2024

The week in pharma: action, reaction and insight – week to October 19 | Pharmaceutical | The Pharmaletter - The Pharma Letter

Oct 20, 2024
pulisher
Oct 20, 2024

Longboard Pharmaceuticals’ stock soars amid Lundbeck’s $2.6 billion deal to acquire the company - MSN

Oct 20, 2024
pulisher
Oct 19, 2024

Longboard Pharmaceuticals Stock Soars 51%. It’s Being Bought for $2.6 Billion. - MSN

Oct 19, 2024
pulisher
Oct 19, 2024

Longboard soars as Lundbeck to buy company for equity value of $2.6B - MSN

Oct 19, 2024
pulisher
Oct 19, 2024

Longboard Pharmaceuticals Strikes $2.6 Billion Deal to Be Acquired by Lundbeck - MSN

Oct 19, 2024
pulisher
Oct 19, 2024

SG Americas Securities LLC Buys Shares of 10,514 Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - MarketBeat

Oct 19, 2024
pulisher
Oct 18, 2024

Dow Surges Over 200 Points; Longboard Pharmaceuticals Shares Jump - MSN

Oct 18, 2024
pulisher
Oct 18, 2024

Taxation With Representation: Baker, Simpson, Ropes - Law360

Oct 18, 2024
pulisher
Oct 17, 2024

Longboard Pharmaceuticals CMO sells $983,936 in stock By Investing.com - Investing.com South Africa

Oct 17, 2024
pulisher
Oct 16, 2024

Randall Kaye Sells 16,667 Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Stock - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Longboard Pharmaceuticals, Inc.LBPH - The Malaysian Reserve

Oct 16, 2024
pulisher
Oct 16, 2024

Longboard Pharmaceuticals (NASDAQ:LBPH) Lowered to Hold at Wedbush - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

Longboard Set to be Acquired by Lundbeck for $2.6B, Stock Soars 52% - MSN

Oct 16, 2024
pulisher
Oct 16, 2024

Lundbeck's billion-dollar acquisition will cost layoffs - MedWatch

Oct 16, 2024
pulisher
Oct 16, 2024

Lundbeck to Acquire Longboard Pharmaceuticals - CHEManager

Oct 16, 2024
pulisher
Oct 15, 2024

Lundbeck’s $2.6 Billion Acquisition of Longboard Pharmaceuticals - Global Legal Chronicle

Oct 15, 2024
pulisher
Oct 15, 2024

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Short Interest Update - MarketBeat

Oct 15, 2024
pulisher
Oct 15, 2024

Lundbeck picks up Longboard Pharmaceuticals for $2.6B - MM+M Online

Oct 15, 2024
pulisher
Oct 15, 2024

Longboard Pharmaceuticals downgraded to Neutral from Buy at B. Riley - TipRanks

Oct 15, 2024
pulisher
Oct 15, 2024

Longboard Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright - TipRanks

Oct 15, 2024
pulisher
Oct 15, 2024

HC Wainwright Reiterates Neutral Rating for Longboard Pharmaceuticals (NASDAQ:LBPH) - MarketBeat

Oct 15, 2024
pulisher
Oct 15, 2024

Longboard Pharma's Lucrative Exit To Lundbeck Another Coup For Management (NASDAQ:LBPH) - Seeking Alpha

Oct 15, 2024
pulisher
Oct 15, 2024

Lundbeck Agrees To Acquire Longboard Pharmaceuticals - Contract Pharma

Oct 15, 2024
pulisher
Oct 15, 2024

Longboard Pharma soars after announcing acquisition by Danish peer - Kursiv Media

Oct 15, 2024
pulisher
Oct 15, 2024

Lundbeck Acquires Longboard Pharmaceuticals for $2.6 Billion - TipRanks

Oct 15, 2024
pulisher
Oct 15, 2024

LBPH Stock Soars 51% as Lundbeck Acquires Longboard Pharmaceuticals for $2.6 Billion - MoneyCheck

Oct 15, 2024
pulisher
Oct 15, 2024

Longboard Pharmaceuticals : Lundbeck to acquire Longboard Pharmaceuticals in a strategic deal, significantly enhancing its neuroscience pipeline Form 8 K - Marketscreener.com

Oct 15, 2024
pulisher
Oct 15, 2024

Danish Lundbeck acquires American Longboard Pharmaceuticals for $2.6 billion - AK&M News

Oct 15, 2024
pulisher
Oct 15, 2024

Denmark: Lundbeck to acquire Longboard Pharmaceuticals - Investors in Healthcare

Oct 15, 2024
pulisher
Oct 15, 2024

Lundbeck agrees to acquire Longboard Pharma for $2.6bn - World Pharmaceutical Frontiers

Oct 15, 2024
pulisher
Oct 15, 2024

Lundbeck forking out $2.6 billion to acquire Longboard Pharma | Biotechnology | The Pharmaletter - The Pharma Letter

Oct 15, 2024
pulisher
Oct 15, 2024

Lundbeck to acquire Longboard Pharmaceuticals for $2.6bn - Pharmaceutical Technology

Oct 15, 2024
pulisher
Oct 15, 2024

Longboard Pharmaceuticals' IPO Lock-up Period Ends On Sep. 8 - RTTNews

Oct 15, 2024

Longboard Pharmaceuticals Inc Azioni (LBPH) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Longboard Pharmaceuticals Inc Azioni (LBPH) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Kaye Randall
CMO
Oct 15 '24
Sale
59.03
16,667
983,936
17,920
Kaye Randall
CMO
Sep 16 '24
Option Exercise
4.35
16,666
72,497
34,586
Kaye Randall
CMO
Sep 16 '24
Sale
31.64
16,666
527,318
17,920
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Capitalizzazione:     |  Volume (24 ore):